Oseltamivir

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

CAS No: 196618-13-0

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Drug substance from the group of neuraminidase inhibitors.

Field of application/useThis section has been translated automatically.

Oseltamivir is offered alongside zanamivir and amantadine as a remedy for true influenza caused by influenza A or B viruses. The drug is said to have a virostatic effect. Its use against avian influenza has been recommended by the WHO. In 2012 and 2014, studies by the Cochrane Collaboration raised doubts about the efficacy and safety of oseltamivir.

IndicationThis section has been translated automatically.

Therapy of viral flu (influenza), post-exposure prophylaxis (prevention after possible contact with an infected person) in children over 1 year of age and in adults approved.

PreparationsThis section has been translated automatically.

Tamiflu®

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer